ClinicalTrials.gg
Not yet recruitingNCT05895526Updated Jun 8, 2023

Comparison of the Effectiveness of Self Etch Adhesive and Fluoride Varnish in Reducing Hypersensitivity in Patients With Gingival Recession

An interventional study of Self etch dentin adhesive, Fluoride varnish in Dentin Sensitivity, sponsored by Prime Foundation. Not yet recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-08.

Sponsored by Prime Foundation · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2023, 3 years 2 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
142
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

Comparison of the clinical effectiveness of self etch adhesive and fluoride varnish in reducing dentin hypersensitivity in patients with gingival recession. A Randomized Clinical Trial

ABSTRACT Objective: To compare the clinical effectiveness of self etch adhesive and fluoride varnish in reducing dentin hypersensitivity in patients with gingival recession

Study Design: Randomized Clinical Trial Place of Study: Department of Operative Dentistry and Endodontics, Peshawar Dental College, Warsak Road.

Methodology: 142 diagnosed cases of Dentin hypersensitivity from outpatient department of nephrology, Prime Hospital Peshawar will be referred to operative department, Peshawar dental college for Comparison of the clinical effectiveness of self etch adhesive and fluoride varnish in reducing dentin hypersensitivity in patients with gingival recession.

Results:

Conclusion:

Read the detailed description

Dentin hypersensitivity is a common disorder and is one of the most irritating clinical condition1. It is one of the everyday complaints from patient visiting dental operatory2. Dentin hypersensitivity has been defined as "Short, sharp pain arising from exposed dentin in response to stimuli typically thermal, evaporative , tactile , osmotic or chemical that cannot be related to any other dental defect or pathology"3'4.Prevalance of dentin hypersensitivity in general population is 4% to 57% 5. Adults are normally affected by dentin hypersensitivity mainly in their late 30s however mainly people aged between 29 to 49 years can also suffer from this6.

One of the most well known theory for dentin hypersensitivity is Brannstorm and Astrom's Hydrodynamic theory2'6. According to this theory environmental ,thermal, chemical changes cause the movement of fluid within tubules, which stimulate terminals of pulpal nerve fibers located in tubules, this will lead to acute transient pain6'7.

Dentin is composed of dentinal tubules and dentin is protected by highly mineralized structures i.e enamel covers the dentin in crown portion while root dentin is protected by cementum8.Certain type of physical, chemical, pathological and biological challenges or developing defects can lead to exposure of dentin. Periodontal tissue loss or gingival recession is one of the most predisposing factor because it will lead to exposure of cervical and root dentin2.

A lot of research has been done on treatment of dentin hypersensitivity but still no consensus has been reached on which product is "gold standard" for treatment of dentin hypersensitivity9.Lukomsky suggested that fluoride can be used as topical desensitizing agent for reduction of DH. It has been in use since 1941.Fluoride causes formation of calcium fluoride crystals and varying degree of fluorapatite which will block the transmission of noxious stimuli to pulp. For treatment of dentin hypersensitivity varnishes containing sodium fluoride as an active component are in use for many years9.Some researchers recommended the use of self etch adhesive for reduction of dentin permeability10.Self etch adhesive form acid resistant hybrid layer due to which they show high level of clinical effectiveness. Yu et al showed that one bottle self etch adhesive plays an effective role in alleviating symptoms of dentin hypersensitivity11.

The aim of current clinical study is to compare clinical effectiveness of self etch and fluoride varnish in reducing dentin hypersensitivity in patients with gingival recession.

Approval to carry out the study was sought from institutional Ethical Review Committee at Peshawar dental college before start of study. Study design was randomized control trial. By using Open epi, the total sample size will be 142 by using a duration of hypersensitivity(pain score) in group A (1.79±1.47) while in group B (2.41±1.22) from a previous study of Ammarah Afreen by keeping 80% Power of the test and 95% confidence interval9.

A prospective randomized clinical study will be planned at Operative Dentistry and Endodontics Department from 12 June, 2023 to 12 ,August 2023.This single center, double blind prospective RCT study will be conducted in Peshawar Dental College and Hospital. The inclusion criteria will be dentin hypersensitivity due to Miller's Class 1 gingival recession, aged between 20-45yrs, without root filled teeth and the patients who are willing to participate in the study. Whereas pregnant and lactating mother, crowned teeth with extensive gingival recession and with cervical restoration will be excluded.

All the selected patients have Miller's Class1 gingival recession in which marginal tissue recession does not extend to the mucogingival junction. Patients were informed regarding purpose, procedure, risk and benefits of the study. Verbal and written informed consent was obtained from all patient regarding his/her participation in study, and they were assured of maintaining confidentiality of the data collected from them. A structured customized performa was specifically designed to record the findings of study. The subjects were randomized by using random number table to minimize bias.

Patients were divided into two groups. The Group 1(Control Group) received the treatment that was based on the fluoride varnish company's instruction whereas Group 2 patients were under treatment regimens based on self etch dentin adhesive company's instruction.Teeth that are hypersensitive were identified using straight probe running cervically evaluating each tooth response. Tooth response to cold air was assessed using standard air syringe of dental unit for one to two seconds. In Group 1, After baseline assessment hypersensitivity were cleaned with cotton pellet soaked in distilled water, fluoride varnish was applied according to company's instruction whereas in group 2 self-etch adhesive, Optibond TM was applied for 20 seconds, dried with high pressure air flow for 5 seconds and light cured for 10 seconds according to manufacturer instruction. All subjects were instructed not to brush their teeth, eat, drink or rinse their mouth for at least two hours after each treatment.

A clinical evaluation of each tooth was assessed by another investigator who was not involved with the treatment procedure. Air stimulation response measurement was done via VAS as the baseline evaluation (T0) before intervention and data was collected, on the day of intervention after application of agents(T1), after one week (T2) and one month after treatment (T3) using tactile and air blast stimuli. The same examiner calculated the total VAS score of each study group at each follow up time from the mean of VAS scores of all treated teeth of every subject in the same group.

Baseline characteristics will also be compared. SPSS 22(SPSS Inc, Chicago, IL) will be used for all statistical analyses. The independent sample t-test will be used to analyze samples. The chi-square test will be used to assess the differences between categoric variables. The comparisons will be considered statistically significant at P \< .05.

02

Conditions studied

  • Dentin Sensitivity

Keywords

  • Dentin permeability
  • Dentin hypersensitivity
  • Gingival recession
03

In context

Dentin Sensitivity

288 studies on the registry are indexed under Dentin Sensitivity; 46 are open to participants now.

This study's planned enrollment of 142 is above the median of 60 across 279 interventional studies indexed under Dentin Sensitivity.

Browse Dentin Sensitivity studies →

Lead sponsor

Prime Foundation is the lead sponsor of 6 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patient with dentin due to gingival recession.
  2. Patients having Miller's Class 1 gingival recession.
  3. Patient aged between 20-45yrs with gingival recession without other periodontal issues.
  4. Patient without root filled teeth.
  5. Patients who are willing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. Teeth with extensive gingival recession.
  2. Teeth with cervical restoration.
  3. Pregnant and lactating mother.
  4. Crowned teeth.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
142 participants (estimated)

Study arms

  • Experimental
    5% Sodium Fluoride Varnish

    71 patients will be in 5% Sodium Fluoride Varnish

    Procedure: Self etch dentin adhesive, Fluoride varnish

  • Experimental
    Self Etch Dentin Adhesive

    71 patients will be in Self Etch Dentin Adhesive

    Procedure: Self etch dentin adhesive, Fluoride varnish

Interventions

  • ProcedureSelf etch dentin adhesive, Fluoride varnish

    After an informed consent, in one group 5% sodium fluoride varnish will be applied in affected area, while the other group will receive self etch dentin adhesive.

06

What researchers measure

Primary outcomes

  1. Comparison of the clinical effectiveness of self etch adhesive and fluoride varnish in reducing dentin hypersensitivity in patients with gingival recession. A Randomized Clinical Trial

    Patients will be divided into two groups. The Group 1 will receive the treatment that is based on the fluoride varnish company's instruction whereas Group 2 patients will under treatment regimens based on self etch dentin adhesive company's instructions.A clinical evaluation of each tooth will be done by another investigator who will not be involved with the treatment procedure. Air stimulation response measurement will be done via Visual analogue scale with score 0( No pain) ,1 2 3 ( Mild pain) , 4 5 6 (Moderate Pain) , 7 8 9 10 (Severe pain).The baseline evaluation (T0) before intervention , on the day of intervention after application of agents(T1), after one week (T2) and one month after treatment (T3) using tactile and air blast stimuli.The same examiner will calculate the total Visual analogue scale score of each study group at each follow up time from the mean of Visual analogue scale scores of all treated teeth of every subject in the same group..

    Time frame: Two months

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2023; primary completion for Aug 2023, 2 months later.

Of 111 non-industry interventional studies with no phase under Dentin Sensitivity, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 12. This study's planned 2 months is below that.

Counting every sponsor, half of 144 studies reached it within 6 months; a quarter within 3 and three quarters within 10.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 12, 2023
First posted
Jun 8, 2023
StartEst.
Jun 12, 2023
Primary completionEst.
Aug 12, 2023
CompletionEst.
Aug 12, 2023
Last update
Jun 8, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05895526
Lead sponsor
Prime Foundation
Responsible party
Iftikhar Akbar (Professor, Prime Foundation) — Principal investigator
First posted
Jun 8, 2023
Start date
Jun 12, 2023 (estimated)
Primary completion
Aug 12, 2023 (estimated)
Completion
Aug 12, 2023 (estimated)
Last update
Jun 8, 2023

Study contacts

Iftikhar Akbar, FCPS, CHPE
Contact
driftikhar156@hotmail.com
00923479368676
Sobia Owais, BDS
Contact
sohakhan9541@gmail.com
Rizwan Qureshi, BDS, FCPS
study chair · Peshawar Dental College

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion